Increased accumulation of LDs in tumor cells involves several signaling pathways, such as activation of the epidermal growth factor receptor and PI3K/AKT/ mammalian target of the rapamycin (mTOR) pathways and inactivation of the FOXO3/SIRT6 pathway [24]. The gene discussed is MTOR; the disease is neoplasm.